← Open Payments lookup

DERICK MOODY: Open Payments

NPI 1235551409 · SPRINGVILLE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,069 in 105 payments from 14 companies in 2025. Trend: 2023 $1,672 · 2024 $1,908 · 2025 $2,069

Food & beverage: $2,069
CompanyPaymentsAmount
ABBVIE INC.19$299
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$286
Takeda Pharmaceuticals U.S.A., Inc.10$189
Neurocrine BioSciences, Inc.8$180
Teva Pharmaceuticals USA, Inc.15$172
Supernus Pharmaceuticals, Inc.6$171
E.R. Squibb & Sons, L.L.C.11$156
Alkermes, Inc.3$144
Janssen Pharmaceuticals, Inc5$113
Otsuka America Pharmaceutical, Inc.5$95

Products named: VRAYLAR, CAPLYTA, TRINTELLIX, REXULTI, INGREZZA, Qelbree, AUSTEDO XR, COBENFY.

Industry payments across UT — which companies pay providers there.